Mirtazapine
Mirtazapine
- Available from pharmacies worldwide (brands include Remeron, Zispin, Mirtazapine Sandoz, among others); mirtazapine is prescription-only (Rx) in Canada and most jurisdictions and is not approved for over-the-counter sale.
- Mirtazapine is used to treat major depressive disorder and off-label for insomnia, anxiety, appetite stimulation and nausea; it is a noradrenergic and specific serotonergic antidepressant (NaSSA) that antagonises central α2‑adrenergic receptors and 5‑HT2/5‑HT3 receptors, increasing noradrenaline and serotonin transmission, and blocks H1 receptors (causing sedation and increased appetite).
- Usual adult dose is 15–45 mg once daily at bedtime (many patients start at 15 mg); lower starting doses (7.5–15 mg) are used for elderly or those sensitive to sedation; dosing should be adjusted in hepatic or severe renal impairment and paediatric use is not routinely recommended.
- Administered orally as tablets (commonly 7.5, 15, 30, 45 mg), orodispersible tablets (15, 30, 45 mg) and occasionally as an oral solution; no routine injectable or topical formulations.
- Onset: sedative effects can occur within hours of the first dose; antidepressant effects are often noticeable after 1–2 weeks, with full response typically by 4–6 weeks.
- Duration of action: once-daily dosing with clinical effects lasting ~24 hours; elimination half-life is roughly 20–40 hours, reaching steady state in several days.
- Alcohol warning: avoid alcohol while taking mirtazapine — co‑use increases sedation and CNS depression, raises risk of respiratory depression, impairment and accidents.
- The most common side effect is somnolence/sedation; other common adverse effects include increased appetite and weight gain, dry mouth, dizziness, constipation and fatigue.
- Would you like to try mirtazapine without a prescription?
Basic Mirtazapine Information
- INN (International Nonproprietary Name): Mirtazapine.
- Brand Names Available In Canada (English): Remeron; generics marketed by manufacturers such as Teva, Sandoz, Mylan and others.
- ATC Code: N06AX11.
- Forms & Dosages: Tablets 7.5 mg (rare), 15 mg, 30 mg, 45 mg; orodispersible tablets 15 mg, 30 mg, 45 mg; oral solution not universally available.
- Manufacturers In Canada (English): Original brand Organon and generics supplied by Teva, Sandoz, Mylan and other regional producers (local repackagers may appear).
- Registration Status In Canada (English): Registered and marketed as Remeron and multiple generics; prescription-only status applies.
- OTC / Rx Classification: Prescription Only (Rx).
Availability & Price Landscape
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Where do Canadians usually find mirtazapine? Community pharmacies across Canada routinely stock mirtazapine under Remeron and multiple generics supplied by Teva, Sandoz, Mylan and others.
Large chains such as Shoppers Drug Mart, Rexall and London Drugs commonly carry standard tablet strengths (15 mg, 30 mg, 45 mg) and may stock orodispersible forms depending on the outlet.
Jean Coutu in Quebec and regional chains in Atlantic and Western Canada also keep mirtazapine in routine inventory, but availability of orodispersible tablets can vary by store.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
Online retail and provincial e-prescription services increasingly fulfil prescriptions for mirtazapine through national retailers' webstores and certified online pharmacies.
Prescription verification and provincial dispensing rules remain in force for online orders, so an authentic prescription is required for dispensing.
Provincial formularies and substitution rules govern which DIN or brand a pharmacist can supply as part of public coverage or professional substitution policies.
Cross-border purchasing from U.S. vendors is still seen among some Canadians, but customers must watch for customs issues, valid prescriptions and Health Canada DIN recognition.
In our online pharmacy, mirtazapine is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Price Ranges By Package Size (With Provincial Differences)
Prices vary by brand (Remeron vs generic), strength (15 mg, 30 mg, 45 mg) and pack size; generics are typically 30–60% cheaper than Remeron.
| Province | Remeron (Typical Retail Category) | Generic Mirtazapine (Typical Retail Category) |
|---|---|---|
| Ontario | Higher; brand pricing applies | Lower; commonly available, ~30–60% less than brand |
| Quebec | Higher; Remeron stocked at major chains and Jean Coutu | Lower; generic substitution common |
| British Columbia | Higher; variable by outlet | Lower; widely stocked, good online availability |
| Alberta | Higher; major chains stock Remeron | Lower; generics competitively priced |
| Manitoba | Higher | Lower |
| Saskatchewan | Higher | Lower |
| Nova Scotia | Higher | Lower |
| New Brunswick | Higher | Lower |
| Prince Edward Island | Higher | Lower |
| Newfoundland & Labrador | Higher | Lower |
Check provincial drug plan formularies (Ontario Drug Benefit, BC PharmaCare, RAMQ in Quebec, etc.) for DIN-linked coverage and special authorizations.
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
What are patients asking online? Canadians report typical experiences on Reddit Canada, HealthBoards and clinic forums, with many threads focused on sleep improvement, appetite changes and daytime sedation.
Community posts often ask about brand interchangeability, timing of doses and whether weight gain is expected.
Reported Benefits And Challenges From Canadian Patients
Sentiment summary (visual): imagine a bar chart where positive bars reflect sleep improvement and appetite increase and negative bars reflect daytime sedation and weight gain.
- Common Themes: Improved sleep within 1–2 weeks, appetite stimulation, helpful for insomnia co‑morbid with depression.
- Common Challenges: Daytime sedation, weight gain, dry mouth and occasional dizziness leading to dose timing adjustments.
- Access Friction: Variable stocking of orodispersible tablets, pharmacist substitution experiences and specialist referral delays.
- Patient Satisfaction Drivers: Clear counselling on bedtime dosing, monitoring weight and explanation of expected sedation.
Product Overview & Brand Variants
INN And Brand Names Used In Canada
- Mirtazapine
- Marketed in Canada as Remeron and as multiple generics by Teva, Sandoz, Mylan and other regional suppliers.
- Remeron
- Original brand commonly stocked in national chains and some hospitals.
- Generic Mirtazapine
- Available in standard tablet and orodispersible presentations; brands and packagers vary by supplier.
Legal Classification Under Health Canada
| Dosage Form | Common Strengths |
|---|---|
| Tablets | 7.5 mg (rare), 15 mg, 30 mg, 45 mg |
| Orodispersible Tablets | 15 mg, 30 mg, 45 mg |
| Oral Solution | Not universally available |
All mirtazapine products are Prescription Only (Rx) and carry a Health Canada Drug Identification Number (DIN) that links to the product monograph and formulary listings.
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
- Major Depressive Disorder in adults is the Health Canada‑approved primary indication for mirtazapine.
- Product monographs linked to each DIN outline recommended dosing of 15–45 mg once daily at bedtime for depression.
Off-Label Patterns In Canadian Healthcare
- Adjunctive or off‑label uses include management of comorbid anxiety with depression and chronic insomnia suspected to be linked to depression.
- Appetite stimulation in palliative or oncology settings and use as adjunct therapy in treatment‑resistant depression occur under specialist guidance.
- Off‑label starting doses (for sleep benefit) may be 7.5–15 mg at bedtime, documented in the patient chart and discussed with informed consent.
How It Works In The Body
Layman’s Explanation (Canadian Patient-Friendly Tone)
Worried about how this pill helps? Mirtazapine helps rebalance brain chemicals involved in mood and sleep, making it easier to fall asleep and improving appetite in many patients.
Taken at night it often reduces anxiety at bedtime and helps sleep onset while boosting appetite over days to weeks.
Clinical Detail From Health Canada Resources
Pharmacologically, mirtazapine is a NaSSA — a noradrenergic and specific serotonergic antidepressant — classified under ATC N06AX11.
It antagonizes central presynaptic alpha‑2 adrenergic autoreceptors and heteroreceptors, increasing noradrenaline and serotonin release.
It also blocks 5‑HT2 and 5‑HT3 receptors and antagonises H1 histamine receptors, which explains its strong sedative effect at lower doses.
Hepatic metabolism yields active metabolites, so dose adjustments and slow titration are advised in liver impairment.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
| Indication/Group | Typical Dosing |
|---|---|
| Adults With Major Depressive Disorder | Start 15 mg once daily at bedtime, titrate up to 45 mg as needed |
| Insomnia Predominant / Lower Dose Strategy | Start 7.5–15 mg at bedtime for sleep benefit |
| Elderly | Start 7.5–15 mg, titrate slowly to minimise sedation and orthostatic effects |
| Liver Impairment | Start low and titrate more slowly due to altered metabolism |
| Renal Impairment | Mild–moderate usually no change; severe impairment requires caution and monitoring |
Adjustments By Patient Type (With Canadian Clinical Notes)
Quick titration flow: start 15 mg qhs → reassess at 2–4 weeks → increase to 30 mg qhs if inadequate response → maximum commonly 45 mg qhs as tolerated.
Elderly patients and those with hepatic impairment begin at the lower end (7.5–15 mg) with smaller upward steps to reduce fall risk.
Orodispersible tablets should be placed on the tongue to dissolve; counsel patients not to chew unless instructed.
Advise no alcohol and caution with driving until individual sedation effects are known.
Contraindications & Side Effects
Common (Health Canada-Approved List)
| Common | Rare But Serious |
|---|---|
|
Somnolence and sedation. Increased appetite and weight gain. Dry mouth. Dizziness. Constipation. Fatigue. |
Blood dyscrasias (rare; monitor CBC if indicated). Seizure exacerbation in predisposed patients. Severe serotoninergic reactions when combined with other serotonergic agents. Transaminase elevations (rare). Cardiac conduction abnormalities in overdose. |
Absolute contraindications include known hypersensitivity to mirtazapine and concurrent or recent MAOI use (allow 14 days washout).
Red Flags: new agitation, suicidal thoughts, signs of allergic reaction, severe dizziness or fainting — seek urgent care.
Rare But Serious (With Canadian Pharmacovigilance Data)
Pharmacovigilance reports note rare blood disorders and hepatic enzyme increases; clinically prompted monitoring may include CBC and LFTs when symptoms suggest.
Use caution in patients with bipolar disorder due to risk of switching to mania, and in those with seizure history.
Comparable Medicines In Canada
Alternatives Table (With DIN References)
| Medicine | Class | Typical Dose | Pros | Cons | DIN |
|---|---|---|---|---|---|
| Sertraline | SSRI | 50–200 mg daily | Well‑tolerated, less sedating | Possible sexual dysfunction | Fetch DIN from Health Canada DB at publication |
| Escitalopram | SSRI | 10–20 mg daily | Good tolerability | Sexual side effects, insomnia in some | Fetch DIN from Health Canada DB at publication |
| Venlafaxine | SNRI | 75–225 mg daily | Efficacy in pain comorbidity | Can raise BP; withdrawal symptoms on stop | Fetch DIN from Health Canada DB at publication |
| Bupropion | Atypical | 150–300 mg daily | Stimulating, less weight gain, low sexual side effects | Contraindicated in seizure risk | Fetch DIN from Health Canada DB at publication |
| Trazodone | Serotonergic antagonist/reuptake inhibitor | 25–150 mg at bedtime (for sleep) | Good sedation for insomnia | Orthostatic hypotension, daytime drowsiness | Fetch DIN from Health Canada DB at publication |
Note: DINs must be fetched from Health Canada’s Drug Product Database at the time of publication and should not be hardcoded.
Pros And Cons List
- SSRIs: Generally well tolerated and less sedating than mirtazapine but may cause sexual dysfunction.
- SNRIs: Useful for comorbid pain but can increase blood pressure and produce withdrawal symptoms.
- Bupropion: Avoid in seizure predisposition but often neutral on weight and sexual side effects.
- Trazodone: Sedating and useful for insomnia, but may not be ideal as a sole antidepressant in some patients.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
Recent research continues to explore mirtazapine’s rapid effect on sleep within depressive episodes and its adjunctive role in treatment‑resistant depression.
Studies and real‑world provincial datasets examine dose–response relationships showing stronger histaminergic sedation at lower doses and metabolic effects with long‑term use.
Ongoing interest includes orodispersible formulations for patients with swallowing difficulties and pharmacogenomic predictors of response.
Canadian centres and international collaborators use observational provincial health data and clinical trials to measure effectiveness and tolerability in routine practice.
When trial data are limited for niche uses, Canadian clinical practice often relies on specialist consensus and careful patient‑centred discussions.
Common Patient Questions In Canada
How quickly will I feel better?
Sleep improvement often appears in 1–2 weeks, while full antidepressant benefit may take 4–6 weeks.
Will it make me gain weight?
Increased appetite and weight gain are commonly reported; discuss regular weight checks and alternative options if weight gain is a concern.
Can I drive?
Avoid driving or operating heavy machinery until you know how sedation affects you, and do not mix with alcohol or other sedatives.
Is it covered by my provincial plan?
Coverage varies by province and by DIN; check Ontario Drug Benefit, BC PharmaCare, RAMQ and local formularies using the product DIN.
Can I stop suddenly?
Gradual tapering is recommended to reduce discontinuation symptoms; follow prescriber instructions for taper schedules.
Pregnancy or breastfeeding?
Use only after specialist risk–benefit discussion; consult obstetrics/psychiatry for pregnancy planning and breastfeeding decisions.
Switching from an SSRI?
Coordinate with your prescriber to account for washout periods and interaction risks, especially with MAOIs.
For urgent mental health crises, contact local emergency services or provincial crisis lines immediately.
Regulatory Status
Health Canada Approval Process
Health Canada reviews quality, safety and efficacy data before approving medicinal products for marketing in Canada.
Approved products receive a Drug Identification Number (DIN) that uniquely identifies the marketed product, manufacturer and approved monograph.
DIN Number Relevance
DINs are essential when checking provincial formularies, reimbursement and pharmacist substitution rules.
Pharmacists and prescribers should verify the DIN at dispensing, particularly when patients request a specific brand or when public coverage requires a particular DIN.
Visual Recommendations
Infographic Ideas For Canadian Context
- Province‑by‑province availability and coverage map that uses DIN lookups to show Remeron and generics on public formularies.
- Dosing flowchart for adults, elderly and hepatic impairment that shows starting dose and titration steps.
- Side‑effect frequency bar chart with a red‑flag callout box for serious reactions and contraindications.
- Comparison snapshot table of alternatives by class, sedation profile and sexual side‑effect risk.
- Packaging gallery showing tablets and orodispersible forms (15/30/45 mg) with clear Canadian English captions and DIN reminder.
Include accessible captions, links to Health Canada monographs and provincial drug plans, and a footer noting that DINs and coverage may change.
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
- Obtain a valid prescription before attempting to purchase; pharmacies will verify and dispense per provincial rules.
- Ask your pharmacist about interchangeability and DIN when offered a generic substitution for Remeron.
- Online pharmacies require e‑prescriptions or scanned prescriptions and must follow provincial dispensing rules and counselling standards.
- Cross‑border purchases may be cheaper but can risk customs seizure and may not have Health Canada‑recognised DINs.
- Compare in‑store counselling and immediate pickup against online convenience and home delivery pricing, factoring in provincial copay rules.
Proper Storage With Canadian Climate Considerations
| Storage Condition | Advice |
|---|---|
| Temperature | Store at 15–30°C (59–86°F); avoid freezing in winter and extreme heat in summer. |
| Light & Moisture | Keep in original packaging away from direct light and moisture. |
| Travel | Carry a copy of your prescription and avoid leaving tablets in hot or freezing vehicles. |
Guidelines For Proper Use
Initial Visit Checklist:
- Confirm indication, current medications and allergy history.
- Start a typical bedside dose (often 15 mg qhs) and explain expected time course for sleep and mood benefits.
- Advise on sedation, alcohol avoidance and driving caution.
Monitoring Plan:
- Follow up at 2–4 weeks to assess response and side effects.
- Monitor weight and blood pressure when clinically indicated.
- Check liver tests and CBC only if symptoms or clinical concern arise.
Taper Schedule Guidance:
- Recommend gradual dose reductions over weeks rather than abrupt discontinuation to reduce withdrawal symptoms.
- Specialist‑led cross‑tap ers may be required when switching antidepressants.
Pharmacist Role:
Verify all concomitant medications (including OTCs and herbal products such as St John’s wort), counsel on sedation and document DIN/brand dispensed.
For emergencies including suicidal ideation or severe allergic reaction, instruct the patient to seek immediate emergency care or contact crisis services.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Victoria | British Columbia | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| London | Ontario | 5-9 days |
| Kitchener | Ontario | 5-9 days |
| St. John’s | Newfoundland & Labrador | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
Visual Recommendations
Recommended captioned visuals include a province availability map, dosing flowchart, side-effect frequency chart and packaging photos to support patient understanding and informed consent.
Closing Practical Notes
Key Takeaway: Mirtazapine (INN) is a widely used prescription antidepressant in Canada marketed as Remeron and multiple generics, most commonly in 15 mg, 30 mg and 45 mg tablets or orodispersible forms.
It is especially useful where insomnia and poor appetite are prominent symptoms and requires cautious dosing in elderly and hepatic impairment.
Pharmacists should confirm the DIN when dispensing and counsel on sedation, weight monitoring and gradual tapering on discontinuation.
For up‑to‑date information on approvals and specific DINs consult Health Canada’s Drug Product Database and provincial formularies at the time of dispensing.